PNC Financial Services Group
ACAD icon

PNC Financial Services Group’s Acadia Pharmaceuticals ACAD Stock Holding History

PNC Financial Services Group’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$114K Buy
4,499
+196
+5% +$4.31K ﹤0.01% 2833
2026
Q1 		$95.8K Sell
4,303
-936
-18% -$22.4K ﹤0.01% 2842
2025
Q4 		$140K Sell
5,239
-84
-2% -$2.01K ﹤0.01% 2564
2025
Q3 		$114K Buy
5,323
+534
+11% +$12.6K ﹤0.01% 2719
2025
Q2 		$103K Sell
4,789
-649
-12% -$12.1K ﹤0.01% 2690
2025
Q1 		$90.3K Buy
5,438
+4,596
+546% +$83.5K ﹤0.01% 2729
2024
Q4 		$15.5K Buy
842
+174
+26% +$2.81K ﹤0.01% 3642
2024
Q3 		$10.3K Sell
668
-155
-19% -$2.59K ﹤0.01% 3790
2024
Q2 		$13.4K Buy
823
+17
+2% +$274 ﹤0.01% 3660
2024
Q1 		$14.9K Buy
806
+183
+29% +$4.53K ﹤0.01% 3589
2023
Q4 		$19.5K Sell
623
-53
-8% -$1.27K ﹤0.01% 3445
2023
Q3 		$14.1K Sell
676
-10
-1% -$272 ﹤0.01% 3611
2023
Q2 		$16.4K Hold
686
– – ﹤0.01% 3637
2023
Q1 		$12.9K Hold
686
– – ﹤0.01% 3694
2022
Q4 		$10.9K Buy
686
+500
+269% +$7.82K ﹤0.01% 3745
2022
Q3 		$2K Buy
186
+61
+49% +$988 ﹤0.01% 4152
2022
Q2 		$1K Sell
125
-472
-79% -$8.81K ﹤0.01% 4306
2022
Q1 		$15K Sell
597
-1,458
-71% -$35.3K ﹤0.01% 3693
2021
Q4 		$49K Buy
2,055
+1,892
+1,161% +$38.1K ﹤0.01% 3123
2021
Q3 		$2K Buy
163
+11
+7% +$212 ﹤0.01% 4075
2021
Q2 		$5K Sell
152
-91
-37% -$2.05K ﹤0.01% 3861
2021
Q1 		$7K Buy
243
+95
+64% +$4.18K ﹤0.01% 3722
2020
Q4 		$7K Sell
148
-300
-67% -$14.9K ﹤0.01% 3638
2020
Q3 		$18K Sell
448
-7,081
-94% -$306K ﹤0.01% 3270
2020
Q2 		$364K Sell
7,529
-675
-8% -$32.4K ﹤0.01% 1567
2020
Q1 		$346K Buy
8,204
+5,536
+207% +$228K ﹤0.01% 1494
2019
Q4 		$115K Sell
2,668
-142,177
-98% -$6.19M ﹤0.01% 2404
2019
Q3 		$5.21M Sell
144,845
-42,931
-23% -$1.3M 0.01% 657
2019
Q2 		$5.02M Sell
187,776
-121,934
-39% -$3.11M ﹤0.01% 698
2019
Q1 		$8.31M Sell
309,710
-85,964
-22% -$2.01M 0.01% 562
2018
Q4 		$6.4M Buy
395,674
+395,427
+160,092% +$7.68M 0.01% 604
2018
Q3 		$5K Sell
247
-172
-41% -$2.71K ﹤0.01% 3814
2018
Q2 		$7K Buy
419
+209
+100% +$3.73K ﹤0.01% 3767
2018
Q1 		$4K Sell
210
-16
-7% -$443 ﹤0.01% 3916
2017
Q4 		$7K Sell
226
-140
-38% -$4.48K ﹤0.01% 3779
2017
Q3 		$14K Sell
366
-1,045
-74% -$34K ﹤0.01% 3543
2017
Q2 		$40K Sell
1,411
-2,973
-68% -$88.6K ﹤0.01% 3019
2017
Q1 		$150K Buy
4,384
+2,548
+139% +$89.9K ﹤0.01% 2273
2016
Q4 		$52K Buy
1,836
+436
+31% +$11.5K ﹤0.01% 2811
2016
Q3 		$44K Sell
1,400
-448
-24% -$15.2K ﹤0.01% 2873
2016
Q2 		$61K Buy
1,848
+1,082
+141% +$36.2K ﹤0.01% 2729
2016
Q1 		$22K Sell
766
-23,445
-97% -$511K ﹤0.01% 3233
2015
Q4 		$863K Buy
24,211
+7,721
+47% +$272K ﹤0.01% 1268
2015
Q3 		$545K Buy
16,490
+410
+3% +$17.1K ﹤0.01% 1513
2015
Q2 		$674K Buy
16,080
+749
+5% +$29K ﹤0.01% 1470
2015
Q1 		$499K Buy
15,331
+13,444
+712% +$462K ﹤0.01% 1644
2014
Q4 		$60K Buy
1,887
+53
+3% +$1.5K ﹤0.01% 2698
2014
Q3 		$45K Sell
1,834
-8,189
-82% -$192K ﹤0.01% 2725
2014
Q2 		$226K Buy
10,023
+1,943
+24% +$40.6K ﹤0.01% 1840
2014
Q1 		$197K Sell
8,080
-2,660
-25% -$67.3K ﹤0.01% 1905
2013
Q4 		$268K Buy
10,740
+2,300
+27% +$54.3K ﹤0.01% 1723
2013
Q3 		$231K Buy
8,440
+7,440
+744% +$156K ﹤0.01% 1779
2013
Q2 		$18K Buy
+1,000
New +$13.8K ﹤0.01% 2776

Other funds holding ACAD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

PNC Financial Services Group's ACAD Position: Q2 2026 in Review

PNC Financial Services Group increased its Acadia Pharmaceuticals (ACAD) stake by 4.6% in Q2 2026, buying an estimated $4.31K and bringing the position to 4,499 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2833.

PNC Financial Services Group first reported a position in ACAD in Q2 2013 and has held it in 53 quarters since. The position peaked at $8.31M in Q1 2019. 175 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • PNC Financial Services Group held 4,499 shares of Acadia Pharmaceuticals worth $114K as of Q2 2026.
  • PNC Financial Services Group bought 196 Acadia Pharmaceuticals shares in Q2 2026, an estimated $4.31K.
  • Acadia Pharmaceuticals made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2833 holding.
  • PNC Financial Services Group first reported a position in Acadia Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • PNC Financial Services Group's Acadia Pharmaceuticals position peaked at $8.31M in Q1 2019.
  • 175 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.